If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,799.50
Bid: 1,796.00
Ask: 1,796.50
Change: 19.00 (1.07%)
Spread: 0.50 (0.028%)
Open: 1,784.00
High: 1,799.50
Low: 1,780.00
Prev. Close: 1,780.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS SUMMARY: Haleon makes positive start separate from GSK

Tue, 20th Sep 2022 10:59

(Alliance News) - The following is a summary of top news stories Tuesday.

----------

COMPANIES

----------

Consumer healthcare firm Haleon, in its first earnings report since being split from pharmaceutical maker GSK and separately listed, reported a strong performance in the first half of 2022, noting double-digit revenue growth during the period. For the six months that ended on June 30, Haleon reported a pretax profit of GBP864 million, up 17% from GBP736 million a year ago, as operating profit increased by 22% to GBP900 million from GBP737 million. Revenue grew 13% to GBP5.19 billion from GBP4.58 billion. In Oral Health, Haleon said revenue grew 5.1% to GBP1.44 billion from GBP1.36 billion a year earlier, maintaining its "track record of market outperformance". Whilst noting current macro-economic challenges and uncertainties, Haleon said the positive momentum seen in the first half has continued into the second half of the year. Haleon said it is confident it is well positioned to deliver on guidance this year. Full-year revenue growth is expected between 6% and 8%.

----------

AstraZeneca said Evusheld has been approved for use in the EU as a treatment for Covid-19. The approval was based on results from the Tackle Phase III Covid-19 treatment trial. This trial showed one intramuscular dose of Evusheld provided "significant" protection against progression to severe Covid-19 or death compared to placebo. Evusheld previously was granted marketing authorisation in the EU for prevention of Covid-19 and is already available in a majority of countries in Europe.

----------

Henkel raised its organic sales outlook for 2022, based on a strong performance seen from the group's Adhesive Technologies business and its plans for a new Consumer Brands unit. For the year, the Dusseldorf, Germany-based chemical and consumer goods firm said it expects organic sales growth to come between 5.5% and 7.5%, compared to prior guidance of a 4.5% to 6.5% increase. Meanwhile, the adjusted return on sales guidance remains unchanged at between 9.0% and 11%. Henkel noted the strong performance from Adhesive Technologies over the third quarter of 2022, which led to an increase in guidance for organic sales growth at between 10% and 12% from between 8.0% and 10%. Henkel said it is continuing to move ahead with the formation of a new Consumer Brands business unit, through the merger of Henkel's Laundry & Home Care and Beauty Care units.

----------

Frasers Group said Founder Mike Ashley will step down from the board, as his son-in-law Michael Murray takes over. Ashley founded the Shirebrook, England-based retail group as 'Mike Ashley Sports' in 1982, evolving into Sports Direct. It now owns many other retail brands including House of Fraser. Ashley holds a 69% stake in the company. In May, Ashley stepped down as chief executive officer, paving the way for son-in-law Murray to become the company's new boss. Previously, Murray was head of 'elevation', meaning upgrading stores. On Tuesday, Frasers said that Ashley will not seek re-election as director at the company's annual general meeting on October 19. It explained that Ashley will continue to be available in an advisory capacity and will inject the company with an additional GBP100 million of funding. This will be on the same terms as its existing unsecured borrowing facilities.

----------

DIY retailer Kingfisher said it delivered a first-half performance in line with expectations, while facing strong comparatives from the prior year as well as a more challenging environment. Sales in the six months that ended July 31 totalled GBP6.81 billion, down 4.1% from GBP7.10 million a year previous. Pretax profit totalled GBP474 million, down 30% against GBP677 million. Kingfisher said it had seen an "encouraging" start to trading in the second half of the year. It declared an unchanged interim dividend of 3.80 pence per share.

----------

Ford affirmed annual guidance but warned on its third-quarter outturn as it grapples with part availability worries. The Detroit-based carmaker said a higher number of vehicles than expected are on the production line awaiting needed parts. It means some deliveries initially planned for the third quarter will only be made in the fourth. The company said "inflation-related supplier costs" will be USD1.0 billion higher than expected in the third quarter.

----------

Chinese electric vehicle manufacturer Zhejiang Leapmotor Technology is hoping to raise more than USD1 billion with an initial public offering in what would be the largest debut so far this year for Hong Kong. The Hangzhou-headquartered company is offering around 131 million shares priced at HKD48 to HKD62, about USD6.10 to USD7.90, according to a prospectus filed with the Hong Kong stock exchange on Tuesday. The listing will be a test of investor appetite in China's EV sector, which has shown huge growth in recent years.

----------

German car rental firm Sixt pledged that at least 70% of its fleet would be made up of hybrid or electric cars by 2030. The proportion of hybrid and electric vehicles in Sixt's global fleet stood at just 10% midway through the year, making the target an ambitious one, though the company said it expected that proportion to rise to between 12% to 15% by the end of 2023. In addition, Sixt plans to make it possible for customers to charge rental cars using German public charging stations during the course of the coming year.

----------

MARKETS

----------

Asian stocks rose on Tuesday but European prices were heading lower, as were Wall Street index futures. Bucking the trend in London, Haleon shares were up 2.1%. Japan and Germany provided further indications of rising global inflationary pressure early in a week that will be dominated by central bank decisions. The US Federal Open Market Committee meeting begins on Tuesday, with an interest rate announcement due on Wednesday. This will be followed by policy decisions from the Bank of Japan, Bank of England and Swiss National Bank on Thursday. On Friday, the UK chancellor will set out his mini-budget, as Parliament gets back to work following the funeral on Monday of Queen Elizabeth II.

----------

CAC 40: down 0.6% at 6,027.57

DAX 40: down 0.5% at 12,739.63

FTSE 100: marginally higher, up 2.36 points at 7,239.04

----------

Hang Seng: closed up 1.2% at 18,781.42

Nikkei 225: closed up 0.4% at 27,688.42

S&P/ASX 200: closed up 1.3% at 6,806.40

----------

DJIA: called down 0.3%

S&P 500: called down 0.4%

Nasdaq Composite: called down 0.5%

----------

EUR: down at USD1.0006 (USD1.0025)

GBP: unchanged at USD1.1429 (USD1.1431)

USD: up at JPY143.68 (JPY142.93)

Gold: down at USD1,668.77 per ounce (USD1,677.01)

Oil (Brent): firm at USD92.64 a barrel (USD92.24)

(currency and commodities changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

The euro area current account swung to a deficit in July, figures from the European Central Bank showed. The eurozone posts an EUR20 billion deficit in July, compared to an EUR4 billion surplus in the previous month, with deficits recorded for goods and secondary income. For the 12 months ended July, the surplus amounted to EUR63 billion, down sharply from EUR370 billion the year prior.

----------

Producer price inflation in Germany accelerated to another record high in August, data from the Federal Statistics Office showed. In August, the producer price index increased by 45.8% compared to the same month a year prior, compared to a 37.2% increase in July, and well above consensus market expectations of a 37.5% hike, according to FXStreet. On a monthly basis, the producer price index rose by 7.9% in August from July, also a record and compared to a 5.3% rise in July from June. The acceleration was due to energy prices, which more than doubled as a result of strong rises electricity and natural gas prices.

----------

The consumer price index in Japan hit 2.8% in August, the highest level since 2014, government data showed Tuesday, as soaring energy prices bite. The last time such figures were seen, prices had been artificially bolstered by an increase in VAT. Excluding years when tax hikes impacted the rate, August's inflation was the fastest pace in nearly 31 years. Data from the internal affairs ministry showed electricity, gas and petrol were among the key contributors to rising prices. The figure for August was slightly above the 2.7% consensus forecast according to FXStreet, and comes on the heels of a 2.4% rise in July. It comes ahead of this week's meeting of the Bank of Japan, which has bucked the trend of peers elsewhere and stuck with its ultra-loose monetary policy.

----------

The People's Bank of China kept its key interest rate unchanged, with the one-year loan prime rate at 3.65%, while the five-year rate remained at 4.3%. The central bank had cut the one-year rate in August from 3.7%, while the five-year rate was reduced from 4.45%.

----------

Minutes from the Reserve Bank of Australia's latest meeting showed that the central bank expects to implement more interest rate hikes as inflation continues to accelerate, but remains mindful of the "risks to growth and employment". Earlier in September, the central bank raised interest rates by half a percentage point to 2.35% from 1.85% previously, its fourth consecutive 50 basis point rate hike. "The size and timing of future interest rate increases will continue to be guided by the incoming data and the board's assessment of the outlook for inflation and the labour market, including the risks to the outlook. All else equal, members saw the case for a slower pace of increase in interest rates as becoming stronger as the level of the cash rate rises," the RBA stated.

----------

UK Prime Minister Liz Truss is committing to spend at least GBP2.3 billion next year on military aid to help Ukraine fend off Vladimir Putin's invasion. Truss pledged the UK will match or exceed the record support given to Volodymyr Zelensky's "inspirational" troops. Truss announced the support as she prepared to fly to New York, where she will use a United Nations summit in the US to rally support in helping Ukraine fight Russia. She will also try to rally world leaders to end energy dependence on Putin's gas as he turns the taps off on the Nord Stream 2 pipeline.

----------

Truss has conceded that negotiations for a post-Brexit free trade deal with the US will not restart for years as she flew to New York ahead of a meeting with Joe Biden. The UK prime minister stressed her trade priority is striking agreements with India and the Gulf states, and joining a trade pact with nations including Australia and Japan. But she heavily downplayed the chances of talks even resuming to get the comprehensive deal with the States that was billed by Brexit backers as a major benefit of leaving the EU during the referendum.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more
20 Feb 2024 08:55

IN BRIEF: Diageo welcomes GSK's CFO as non-executive director

Diageo PLC - London-based brewer and distiller sells more than 200 drinks brands, including Guinness stout, Captain Morgan rum and Johnnie Walker whisky - Appoints GSK PLC's chief financial officer and executive director, Julie Brown, as a non-executive director. Says she will succeed Alan Stewart as chair of the audit committee after his retirement following the firm's annual general meeting in September. Chair Javier Ferran says: "Julie brings many years of experience in financial, commercial and strategic roles in international companies operating in highly regulated industries. She is strongly committed to enabling diversity in business and to creating sustainable, long-term value for stakeholders. I look forward to her contribution to Board discussions and to working with her in progressing Diageo's ambition to be one of the most trusted and respected consumer products companies in the world."

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
15 Feb 2024 11:02

Berenberg hikes target price on GSK

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker GSK from £16.50 to £18.20 on Thursday, stating the group was moving closer to offsetting losses associated with the expiry of its patent on HIV drug dolutegravir.

Read more
15 Feb 2024 09:45

LONDON BROKER RATINGS: Jefferies cuts Kingfisher but Citi raises

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
15 Feb 2024 08:49

GSK completes USD1.4 billion purchase of respiratory firm Aiolos Bio

(Alliance News) - GSK PLC on Thursday said it has completed the acquisition of Aiolos Bio Ltd, expanding its respiratory portfolio with a potential "best-in-class" asthma treatment.

Read more
13 Feb 2024 16:53

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.